Globally, more than 37 million people are living with HIV, nearly two-thirds of them in Africa.
Despite a decades-long effort, there is still no vaccine available to prevent HIV infection.
In conjunction with HIV Vaccine Awareness Day — an observance led by the National Institute of Allergy and Infectious Diseases — Moderna on Wednesday announced the start of a phase 1 clinical trial of an HIV messenger RNA vaccine candidate in Rwanda and South Africa.
To mark the day, we compiled a list of other recent stories showcasing HIV vaccine research.
After more than 40 years, ‘HIV